[Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects].
BACKGROUND
Candida albicans has a variety of virulence factors, including secreted aspartyl proteases, which are determinant factors in the pathogenesis of this yeast in immunocompromised patients.


OBJECTIVE
Proteinase activity was identified in C. albicans strains isolated from the oral cavity of immunocompromised patients with cancer, diabetes and HIV+, with oral candidiasis and in healthy subjects.


METHODS
Two hundred and fifty C. albicans strains were analyzed, distributed in 5 different groups: patients with cancer, diabetes, HIV+, with oral candidiasis and healthy subjects.


RESULTS
Proteolytic activity was identified in 46% of the strains from cancer patients, 54% from HIV+ patients, 60% from diabetics, 70% from oral candidiasis patients, and 42% from healthy subjects. Activity was higher in strains from immunocompromised and oral candidiasis patients than in healthy subjects. Differences were observed between the candidiasis-healthy, candidiasis-HIV+, and diabetic-healthy groups. No differences were observed between the oral candidiasis, diabetes and cancer patients, between the diabetes and HIV+ patients, or between the cancer patients, HIV+ patients and healthy subjects.


CONCLUSIONS
The present results suggest that although secreted aspartyl proteases are important in the pathogenesis of C. albicans, their activity depends on host conditions.
Departamento de Microbiología Oral y Biología Molecular, Facultad de Odontología, Universidad Autónoma de Yucatán, Mérida, Yucatán, México. Electronic address: hsolis@uady.mx.
Sandra E
SE
Hernández-Solís
Departamento de Microbiología Oral y Biología Molecular, Facultad de Odontología, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
Florencio
F
Rueda-Gordillo
Laboratorio de Biotecnología, Facultad de Ingeniería Química, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
Rafael A
RA
Rojas-Herrera
D002176:Candida albicans / Q000201:enzymology* / Q000302:isolation & purification / Q000472:pathogenicity; D002180:Candidiasis, Oral / Q000382:microbiology*; D002353:Carrier State / Q000382:microbiology; D048909:Diabetes Complications / Q000382:microbiology; D005656:Fungal Proteins / Q000032:analysis*; D015658:HIV Infections / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D008800:Mexico; D009055:Mouth / Q000382:microbiology*; D009369:Neoplasms / Q000150:complications; D010447:Peptide Hydrolases / Q000032:analysis*; D014774:Virulence
D005656:Fungal Proteins; D010447:Peptide Hydrolases
Cancer; Candida albicans; Candidiasis oral; Cáncer; Diabetes; Factores de virulencia; Healthy carriers; Human immunodeficiency virus; Oral candidiasis; Portadores sanos; Proteinasa; Proteinase; Virulence factors; Virus de la inmunodeficiencia humana